ORTX — Orchard Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Orchard Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	20-F	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	336	325	192	220	144
Net Total Accounts Receivable
Net Total Receivables	12.7	16.4	21	36.7	17.3
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	356	350	224	275	168
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	5.48	27	34.6	29.1	30.9
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	366	399	281	322	219
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	47.9	55.9	51.6	42.8	60.6
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	54.7	100	103	112	121
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	311	299	178	210	98.3
Total Liabilities & Shareholders' Equity	366	399	281	322	219
Total Common Shares Outstanding